Cytogenetic evaluation of the mechanism of cell death induced by the novel anthracenyl-amino acid topoisomerase II catalytic inhibitor NU / ICRF 500
- 1 August 1995
- journal article
- Published by Elsevier in Mutation Research/Genetic Toxicology
- Vol. 344 (1-2) , 55-62
- https://doi.org/10.1016/0165-1218(95)90038-1
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Biochemistry of topoisomerase I and II inhibition by anthracenyl-amino acid conjugatesBiochemical Pharmacology, 1995
- Inhibitors of Topoisomerase II Delay Progress through Mitosis and Induce a Doubling of the DNA Content in CHO CellsExperimental Cell Research, 1995
- DNA Topoisomerases: Essential Enzymes and Lethal TargetsAnnual Review of Pharmacology and Toxicology, 1994
- When good enzymes go bad: Conversion of topoisomerase II to a cellular toxin by antineoplastic drugsChemical Research in Toxicology, 1993
- Topoisomerase inhibitors induce apoptosis in thymocytesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1993
- Changes in nuclear chromatin related to apoptosis or necrosis induced by the DNA topoisomerase II inhibitor fostriecin in MOLT-4 and HL-60 cells are revealed by altered DNA sensitivity to denaturationExperimental Cell Research, 1992
- Association of topoisomerase II with the hepatoma cell nuclear matrix: The role of intermolecular disulfide bond formationExperimental Cell Research, 1991
- Micronuclei as an index of cytogenetic damage: Past, present, and futureEnvironmental and Molecular Mutagenesis, 1991
- Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sitesCell, 1986
- Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase IIScience, 1984